It suggests that a global increase in DNMT3a in a highly stressed breast cancer patient might result in the silencing or downregulation of NR3C1 and interfere with the regulation of the stress response, mediated by NR3C1. The gene discussed is DNMT3A; the disease is breast carcinoma.